Latigo Biotherapeutics logo

Latigo Biotherapeutics

Thousand Oaks, CA

Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain. The company utilizes unique, translated insights to provide a differentiated approach to targeting therapeutics across the blood-nerve barrier, enabling patients to get access to a pain management therapy that does not create addiction, dependence or tolerability.

latigobio.com

Company Details

Founded

2018

Employees

Between 10 - 50 employees

Raised

$300,000,000

Headquarters Location

Thousand Oaks, CA

Public

No

Acquired

No

CEO

Scott WassermanScott Wasserman

Company Collections

These are collections Latigo Biotherapeutics is a part of. Click on the collection name to view similar companies.

Latigo Biotherapeutics' Industries

Latigo Biotherapeutics Headquarters Location

Thousand Oaks, CA 91360

Total Amount Raised: $300,000,000

Latigo Biotherapeutics Funding Rounds

  • Series B

    $150,000,000

    Series B Investors

    Blue Owl Capital
    KERN CAPITAL PTY.
    Sanofi
    Qatar Investment Authority
    Deep Track Capital
    University of Pittsburgh Medical Center (UPMC)
    Rock Springs Capital
    Access Industries
    Cormorant Asset Management
    Alexandria Real Estate Equities
    Westlake Village BioPartners
    5am Ventures
    Foresite Capital
  • Series A

    $135,000,000

    Series A Investors

    5am Ventures
    Foresite Capital
    Westlake Village BioPartners
    Corner Ventures
  • Series Unknown

    $15,000,000

    Series Unknown Investors

    Corner Ventures
Funding info provided by Diffbot.

Latigo Biotherapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Latigo Biotherapeutics.

Recent reviews